Efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy combined with temozolomide for the postoperative treatment of glioblastoma multiforme: a single-institution experience

PURPOSE: Despite recent advances in multimodal treatments, the prognosis of patients with glioblastoma multiforme (GBM) remains poor. The aim of this study was to evaluate the efficacy of moderately hypofractionated simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) combined w...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Liangzhi, Chen, Lu, Lv, Shengqing, Li, Qingrui, Chen, Guangpeng, Luo, Wen, Zhou, Pu, Li, Guanghui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567425/
https://www.ncbi.nlm.nih.gov/pubmed/31196126
http://dx.doi.org/10.1186/s13014-019-1305-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567425/
https://www.ncbi.nlm.nih.gov/pubmed/31196126
http://dx.doi.org/10.1186/s13014-019-1305-1

Ejemplares similares